ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2083

Epistasis between HLA-B27 and ERAP1 Affects Gut Microbial Dysbiosis and Arthritis in Experimental Spondyloarthritis

Tejpal Gill1, Tri Tran1, Stephen R. Brooks2 and Robert Colbert3, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2Biodata Mining and Discovery Section, Office of Science and Technology, NIAMS/NIH, Bethesda, MD, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Arthritis, inflammation and microbiome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Common variants in endoplasmic reticulum (ER)-associated aminopeptidase-1 (ERAP1) affect susceptibility to spondyloarthritis (SpA) in HLA-B27-positive human subjects, with loss-of-function/expression conferring protection. Using HLA-B27/human b2-microglobulin transgenic (HLA-B27 TG) rats, an experimental model of SpA, we have preliminary results that ERAP1 deficiency partially protects from the development of arthritis and orchitis, but not gut inflammation. The mechanism(s) underlying the protective effect of ERAP1 loss-of-function remain unknown. Here, we examined the gut microbiota of HLA-B27-TG rats with and without arthritis and with different ERAP1 genotypes, with the goal of identifying arthritis-associated gut microbes.

Methods: Cohorts of HLA-B27-TG rats with 3 ERAP1 genotypes (+/+, +/−, and −/−) were generated by crossing HLA-B27-TG Lewis (LEW) rats with Sprague-Dawley (SD) rats carrying 0, 1, or 2 ERAP1 null alleles. The mixed LEW-SD background (SDM) accelerates the onset of arthritis and orchitis, while gut inflammation remains unchanged. Animals were examined 2-3 times per week for the presence of arthritis and orchitis for up to 6 months and then euthanized. Gut inflammation in the cecum and colon was assessed by histological scoring. Microbial profiles were determined using DNA isolated from the cecum luminal contents, with 16S rRNA gene sequencing performed using Illumina MiSeq. Data were quality-filtered using Quantitative Insights Into Microbial Ecology (QIIME 2). Microbe relative frequency was determined at the species level (maximum >0.1%; p<0.05, q<0.1).

Results: HLA-B27 TG SDM rats with arthritis have a distinct gut microbial signature compared to HLA-B27 TG non-arthritic SDM rats as measured by principal component analysis, despite similar gut histology scores. Moreover, arthritis-associated microbes differ from HLA-B27-assocated dysbiotic microbes. Arthritis is associated with a significant loss of microbial alpha diversity, as well as differences in microbial community structure. HLA-B27 TG SDM rats with arthritis have increased Bacteroidesand Parabacteroidesat the expense of Firmicutes. At the species level, we see an increased relative frequency of certain microbes such as Akkermansia muciniphilaand Blautia, that are often associated with inflammation, whereas other inflammation-associated microbes ([Prevotella], Lachnospiraceae, [Ruminococcus] gnavus) were decreased in comparison with non-arthritic HLA-B27 TG rats. Further analysis based upon different ERAP1 genotypes also revealed ERAP1-associated differences on the microbial diversity and community structure.

Conclusion: In-depth analysis of HLA-B27 TG rats with and without arthritis has revealed the presence of arthritis-associated microbiota, which may explain why only some animals develop arthritis. These distinct arthritis-associated microbial communities will be further tested by microbiota transfer experiments in other genetic backgrounds. These results may provide valuable insights into the relationship between HLA-B27 and ERAP1, and their effects on arthritis and gut inflammation in experimental spondyloarthritis.


Disclosure: T. Gill, None; T. Tran, None; S. R. Brooks, None; R. Colbert, None.

To cite this abstract in AMA style:

Gill T, Tran T, Brooks SR, Colbert R. Epistasis between HLA-B27 and ERAP1 Affects Gut Microbial Dysbiosis and Arthritis in Experimental Spondyloarthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/epistasis-between-hla-b27-and-erap1-affects-gut-microbial-dysbiosis-and-arthritis-in-experimental-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epistasis-between-hla-b27-and-erap1-affects-gut-microbial-dysbiosis-and-arthritis-in-experimental-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology